This document is an excerpt from the EUR-Lex website
Document 32023R1545R(02)
Corrigendum to Commission Regulation (EU) 2023/1545 of 26 July 2023 amending Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards labelling of fragrance allergens in cosmetic products (OJ L 188, 27.7.2023)
Corrigendum to Commission Regulation (EU) 2023/1545 of 26 July 2023 amending Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards labelling of fragrance allergens in cosmetic products (OJ L 188, 27.7.2023)
Corrigendum to Commission Regulation (EU) 2023/1545 of 26 July 2023 amending Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards labelling of fragrance allergens in cosmetic products (OJ L 188, 27.7.2023)
C/2025/7488
OJ L, 2025/90876, 11.11.2025, ELI: http://data.europa.eu/eli/reg/2023/1545/corrigendum/2025-11-07/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
ELI: http://data.europa.eu/eli/reg/2023/1545/corrigendum/2025-11-07/oj
|
Official Journal |
EN L series |
|
2025/90876 |
11.11.2025 |
Corrigendum to Commission Regulation (EU) 2023/1545 of 26 July 2023 amending Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards labelling of fragrance allergens in cosmetic products
( Official Journal of the European Union L 188 of 27 July 2023 )
|
1. |
On page 8, in the Annex, point (1) (replacing entry 157 of Annex III to Regulation (EC) No 1223/2009): |
for:
|
Reference number |
Substance identification |
Restrictions |
Wording of conditions of use and warnings |
|||||||||||||
|
Chemical Name/INN |
Name of Common Ingredients Glossary |
CAS number |
EC number |
Product type, body parts |
Maximum concentration in ready for use preparation |
Other |
||||||||||
|
a |
b |
c |
d |
e |
f |
g |
h |
i |
||||||||
|
‘157 |
1-(2,6,6-trimethyl-2- cyclohexen-1-yl)-2-buten-1-one (16) (**) |
Alpha-Damascone; |
43052-87-5/ |
-/ |
|
|
(a) (b) The presence of the substance or substances shall be indicated as “Rose Ketones” in the list of ingredients referred to in Article 19(1), point (g), when the concentration of the substance or substances exceeds:
|
|
||||||||
|
cis-Rose ketone 1 |
23726-94-5 |
245-845-8 |
|
|||||||||||||
|
trans-Rose ketone 1 |
24720-09-0 |
246-430-4 |
||||||||||||||
|
1-(2,6,6-Trimethyl cyclohexa-1,3-dien- 1-yl)-2-buten-1-one(16) (**) |
Rose ketone 4 (Damascone) |
23696-85-7 |
245-833-2 |
|||||||||||||
|
1-(2,6,6-Trimethyl- 3-cyclohexen-1-yl)- 2-buten-1-one(16) (**) |
Rose ketone 3 (delta-Damascone) |
57378-68-4 |
260-709-8 |
|||||||||||||
|
trans-Rose ketone 3 |
71048-82-3 |
275-156-8 |
||||||||||||||
|
(Z)-1-(2,6,6- trimethyl-1-cyclo hexen-1- yl)-2-buten-1-one(16) (**) |
cis-Rose ketone 2 (cis-beta-Damascone) |
23726-92-3 |
245-843-7 |
|||||||||||||
|
(E)-1-(2,6,6- Trimethyl-1-cyclo hexen-1-yl)-2-buten-1-one(16) (**) |
trans-Rose ketone 2 (trans-beta-Damascone) |
23726-91-2 |
245-842-1 |
|||||||||||||
read:
|
Reference number |
Substance identification |
Restrictions |
Wording of conditions of use and warnings |
|||||||||||||
|
Chemical Name/INN |
Name of Common Ingredients Glossary |
CAS number |
EC number |
Product type, body parts |
Maximum concentration in ready for use preparation |
Other |
||||||||||
|
a |
b |
c |
d |
e |
f |
g |
h |
i |
||||||||
|
‘157 |
1-(2,6,6-trimethyl-2- cyclohexen-1-yl)-2-buten-1-one(16) (**) |
Alpha-Damascone; |
43052-87-5/ |
-/ |
|
|
(a) (b) The presence of the substance or substances shall be indicated as “Rose Ketones” in the list of ingredients referred to in Article 19(1), point (g), when the concentration of the substance or substances exceeds:
|
|
||||||||
|
cis-Rose ketone 1 |
23726-94-5 |
245-845-8 |
|
|||||||||||||
|
trans-Rose ketone 1 |
24720-09-0 |
246-430-4 |
||||||||||||||
|
1-(2,6,6-Trimethyl cyclohexa-1,3-dien-1-yl)-2-buten-1-one(16) (**) |
Rose ketone 4 (Damascenone) |
23696-85-7 |
245-833-2 |
|||||||||||||
|
1-(2,6,6-Trimethyl- 3-cyclohexen-1-yl)-2-buten-1- one(16) (**) |
Rose ketone 3 (delta-Damascone) |
57378-68-4 |
260-709-8 |
|||||||||||||
|
trans-Rose ketone 3 |
71048-82-3 |
275-156-8 |
||||||||||||||
|
(Z)-1-(2,6,6- trimethyl-1-cyclo hexen-1-yl)-2-buten-1-one(16) (**) |
cis-Rose ketone 2 (cis-beta-Damascone) |
23726-92-3 |
245-843-7 |
|||||||||||||
|
(E)-1-(2,6,6- Trimethyl-1-cyclo hexen-1-yl)-2-buten-1-one(16) (**) |
trans-Rose ketone 2 (trans-beta-Damascone) |
23726-91-2 |
245-842-1 |
|||||||||||||
|
2. |
On page 21, in the Annex, point (3) (adding entry 364 to Annex III to Regulation (EC) No 1223/2009): |
for:
|
Reference number |
Substance identification |
Restrictions |
Wording of conditions of use and warnings |
|||||||||
|
Chemical Name/INN |
Name of Common Ingredients Glossary |
CAS number |
EC number |
Product type, body parts |
Maximum concentration in ready for use preparation |
Other |
||||||
|
a |
b |
c |
d |
e |
f |
g |
h |
i |
||||
|
‘364 |
Pelargonium graveolens oil (*) |
Pelargonium Graveolens Flower Oil |
90082-51-2/ 8000-46-2 |
290-140-0/ - |
|
|
The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds:
|
|
||||
read:
|
Reference number |
Substance identification |
Restrictions |
Wording of conditions of use and warnings |
|||||||||
|
Chemical Name/INN |
Name of Common Ingredients Glossary |
CAS number |
EC number |
Product type, body parts |
Maximum concentration in ready for use preparation |
Other |
||||||
|
a |
b |
c |
d |
e |
f |
g |
h |
i |
||||
|
‘364 |
Pelargonium graveolens oil (*) |
Pelargonium Graveolens Oil Pelargonium Graveolens Flower Oil Pelargonium Graveolens Leaf Oil |
90082-51-2/ 8000-46-2 |
290-140-0/ - |
|
|
The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds:
|
|
||||
|
3. |
On page 21, in the Annex, point (3) (adding entry 365 to Annex III to Regulation (EC) No 1223/2009): |
for:
|
Reference number |
Substance identification |
Restrictions |
Wording of conditions of use and warnings |
|||||||||
|
Chemical Name/INN |
Name of Common Ingredients Glossary |
CAS number |
EC number |
Product type, body parts |
Maximum concentration in ready for use preparation |
Other |
||||||
|
a |
b |
c |
d |
e |
f |
g |
h |
i |
||||
|
‘365 |
Pogostemon cablin oil (*) |
Pogostemon Cablin Oil |
8014-09-3/ 84238-39-1 |
-/ 282-493-4 |
|
|
The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds:
|
|
||||
read:
|
Reference number |
Substance identification |
Restrictions |
Wording of conditions of use and warnings |
|||||||||
|
Chemical Name/INN |
Name of Common Ingredients Glossary |
CAS number |
EC number |
Product type, body parts |
Maximum concentration in ready for use preparation |
Other |
||||||
|
a |
b |
c |
d |
e |
f |
g |
h |
i |
||||
|
‘365 |
Pogostemon cablin oil (*) |
Pogostemon Cablin Oil Pogostemon Cablin Leaf Oil |
8014-09-3/ 84238-39-1 |
-/ 282-493-4 |
|
|
The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds:
|
|
||||
ELI: http://data.europa.eu/eli/reg/2023/1545/corrigendum/2025-11-07/oj
ISSN 1977-0677 (electronic edition)